ABCDx Company

ABCDx (Advanced Brain Companion Diagnostics) is a privately-funded start-up company founded in 2014 by three experienced individuals: Two eminent researchers from the Faculty of Medicine of the University of Geneva and the Vall d’Hebron Research Institute (VHIR) at Vall d’Hebron Hospital, Barcelona. Recognized as key opinion leaders in the field of brain biomarkers, they combine expertise in biomarker discovery, validation and clinical experience. The third founder of ABCDx is an experienced industry and licensing executive with experience in both established and start-up diagnostic and pharmaceutical ventures. Transforming care for patients with brain injury. ABCDx provides powerful new tools for transforming the triage, diagnosis and treatment decision process at the point of care for patients presenting with potential brain injury from stroke and trauma to complications. ABCDx is pioneering the ability to decode the chemical messages of the brain so that brain injury can be detected earlier often before hospitalization and from a single blood drop


Technology: Neuroscience
Industry: BioTech
Headquarters: Geneva
Founded Date: 2014

Visit Website
Register and Claim Ownership